|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income (expense): | ||||
| Change in fair value of financial instruments | ||||
| Interest expense | ||||
| Other income | ||||
| Total other income, net | ||||
| Net (loss) income | ||||
| Foreign currency translation adjustment | ||||
| Comprehensive income (loss) | ||||
| Net (loss) income per share, basic | ||||
| Net (loss) income per share, diluted | ||||
| Weighted-average outstanding Common Shares, basic | ||||
| Weighted-average outstanding Common Shares, diluted | ||||
Loading...